|
1
|
Ryan KK, Li B, Grayson BE, Matter EK,
Woods SC and Seeley RJ: A role for central nervous system PPAR-γ in
the regulation of energy balance. Nat Med. 17:623–626. 2011.
|
|
2
|
Cipolletta D, Feuerer M, Li A, Kamei N,
Lee J, Shoelson SE, Benoist C and Mathis D: PPAR-γ is a major
driver of the accumulation and phenotype of adipose tissue Treg
cells. Nature. 486:549–553. 2012.
|
|
3
|
Sun K and Scherer PE: The PPARγ-FGF1 axis:
an unexpected mediator of adipose tissue homeostasis. Cell Res.
22:1416–1418. 2012.
|
|
4
|
Jonker JW, Suh JM, Atkins AR, Ahmadian M,
Li P, Whyte J, He M, Juguilon H, Yin YQ, Phillips CT, Yu RT,
Olefsky JM, Henry RR, Downes M and Evans RM: A PPARγ-FGF1 axis is
required for adaptive adipose remodelling and metabolic
homeostasis. Nature. 485:391–394. 2012.
|
|
5
|
Tyagi S, Gupta P, Saini AS, Kaushal C and
Sharma S: The peroxisome proliferator-activated receptor: a family
of nuclear receptors role in various diseases. J Adv Pharm Technol
Res. 2:236–240. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Svendsen PF, Christiansen M, Hedley PL,
Nilas L, Pedersen SB and Madsbad S: Adipose expression of
adipocytokines in women with polycystic ovary syndrome. Fertil
Steril. 98:235–241. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dasgupta S, Sirisha P, Neelaveni K,
Anuradha K, Sudhakar G and Reddy BM: Polymorphisms in the IRS-1 and
PPAR-γ genes and their association with polycystic ovary syndrome
among South Indian women. Gene. 503:140–146. 2012.
|
|
8
|
Saraf N, Sharma PK, Mondal SC, Garg VK and
Singh AK: Role of PPARg2 transcription factor in
thiazolidinedione-induced insulin sensitization. J Pharm Pharmacol.
64:161–171. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Amalfi S, Velez LM, Heber MF, Vighi S,
Ferreira SR, Orozco AV, Pignataro O and Motta AB: Prenatal
hyperandrogenization induces metabolic and endocrine alterations
which depend on the levels of testosterone exposure. PLoS One.
7:e376582012. View Article : Google Scholar
|
|
10
|
Lenarcik A, Bidzińska-Speichert B,
Tworowska-Bardzińska U and Krępuła K: Hormonal abnormalities in
first-degree relatives of women with polycystic ovary syndrome
(PCOS). Endokrynol Pol. 62:129–133. 2011.PubMed/NCBI
|
|
11
|
Abramovich D, Irusta G, Bas D, Cataldi NI,
Parborell F and Tesone M: Angiopoietins/TIE2 system and VEGF are
involved in ovarian function in a DHEA rat model of polycystic
ovary syndrome. Endocrinology. 153:3446–3456. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Glintborg D, Andersen M, Hagen C, Frystyk
J, Hulstrøm V, Flyvbjerg A and Hermann AP: Evaluation of metabolic
risk markers in polycystic ovary syndrome (PCOS). Adiponectin,
ghrelin, leptin and body composition in hirsute PCOS patients and
controls. Eur J Endocrinol. 155:337–345. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Henmi H, Endo T, Nagasawa K, Hayashi T,
Chida M, Akutagawa N, Iwasaki M, Kitajima Y, Kiya T, Nishikawa A,
Manase K and Kudo R: Lysyl oxidase and MMP-2 expression in
dehydroepiandrosterone-induced polycystic ovary in rats. Biol
Reprod. 64:157–162. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rosenfield RL, Mortensen M, Wroblewski K,
Littlejohn E and Ehrmann DA: Determination of the source of
androgen excess in functionally atypical polycystic ovary syndrome
by a short dexamethasone androgen-suppression test and a low-dose
ACTH test. Hum Reprod. 26:3138–3146. 2011.PubMed/NCBI
|
|
15
|
Wang YX, Xie XM and Zhu WJ: Serum
adiponectin and resistin levels in patients with polycystic ovarian
syndrome and their clinical implications. J Huazhong Univ Sci
Technolog Med Sci. 30:638–642. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang YX, Sun YY and Qiu HY: Expression of
resistin mRNA in adipose tissue of rat model with polycystic
ovarian syndrome and its implication. J Huazhong Univ Sci Technolog
Med Sci. 24:621–624. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Knebel B, Lehr S, Janssen OE, Hahn S,
Nitzgen U, Jacob S, Haas J, Muller-Wieland D and Kotzka J: Genetic
variants in central metabolic genes influence some but not all
relations of inflammatory markers in a collective with polycystic
ovary syndrome. Arch Physiol Biochem. 118:219–229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang H, Bi Y, Hu C, Lu W and Zhu D:
Association between the Pro12Ala polymorphism of PPAR-γ gene and
the polycystic ovary syndrome: a meta-analysis of case-control
studies. Gene. 503:12–17. 2012.
|
|
19
|
San-Millán JL and Escobar-Morreale HF: The
role of genetic variation in peroxisome proliferator-activated
receptors in the polycystic ovary syndrome (PCOS): an original
case-control study followed by systematic review and meta-analysis
of existing evidence. Clin Endocrinol (Oxf). 72:383–392. 2010.
|
|
20
|
Brettenthaler N, De Geyter C, Huber PR and
Keller U: Effect of the insulin sensitizer pioglitazone on insulin
resistance, hyperandrogenism, and ovulatory dysfunction in women
with polycystic ovary syndrome. J Clin Endocrinol Metab.
89:3835–3840. 2004. View Article : Google Scholar
|
|
21
|
Yildiz BO, Yarali H, Oguz H and Bayraktar
M: Glucose intolerance, insulin resistance, and hyperandrogenemia
in first degree relatives of women with polycystic ovary syndrome.
J Clin Endocrinol Metab. 88:2031–2036. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brennan K, Huang A and Azziz R:
Dehydroepiandrosterone sulfate and insulin resistance in patients
with polycystic ovary syndrome. Fertil Steril. 91:1848–1852. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kajita K, Ishizuka T, Mune T, Miura A,
Ishizawa M, Kanoh Y, Kawai Y, Natsume Y and Yasuda K:
Dehydroepiandrosterone down-regulates the expression of peroxisome
proliferator-activated receptor gamma in adipocytes. Endocrinology.
144:253–259. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yogosawa S, Mizutani S, Ogawa Y and Izumi
T: Activin receptor-like kinase 7 suppresses lipolysis to
accumulate fat in obesity through downregulation of peroxisome
proliferator-activated receptor γ and C/EBPα. Diabetes. 62:115–123.
2012.PubMed/NCBI
|
|
25
|
Swaroop JJ, Rajarajeswari D and Naidu JN:
Association of TNF-α with insulin resistance in type 2 diabetes
mellitus. Indian J Med Res. 135:127–130. 2012.
|
|
26
|
Wang F, Gao L, Gong B, Hu J, Li M, Guan Q
and Zhao J: Tissue-specific expression of PPAR mRNAs in diabetic
rats and divergent effects of cilostazol. Can J Physiol Pharmacol.
86:465–471. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sharma AK, Bharti S, Ojha S, Bhatia J,
Kumar N, Ray R, Kumari S and Arya DS: Up-regulation of PPARγ, heat
shock protein-27 and -72 by naringin attenuates insulin resistance,
β-cell dysfunction, hepatic steatosis and kidney damage in a rat
model of type 2 diabetes. Br J Nutr. 106:1713–1723. 2011.
|
|
28
|
Kim J, Sato M, Li Q, Lydon JP, Demayo FJ,
Bagchi IC and Bagchi MK: Peroxisome proliferator-activated receptor
gamma is a target of progesterone regulation in the preovulatory
follicles and controls ovulation in mice. Mol Cell Biol.
28:1770–1782. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Asrih M, Lerch R, Papageorgiou I, Pellieux
C and Montessuit C: Differential regulation of stimulated glucose
transport by free fatty acids and PPARα or -δ agonists in cardiac
myocytes. Am J Physiol Endocrinol Metab. 302:E872–E884.
2012.PubMed/NCBI
|
